Blueprint Medicines Statistics
Total Valuation
BPMC has a market cap or net worth of $5.27 billion. The enterprise value is $4.91 billion.
| Market Cap | 5.27B |
| Enterprise Value | 4.91B |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BPMC has 61.23 million shares outstanding. The number of shares has increased by 1.54% in one year.
| Shares Outstanding | 61.23M |
| Shares Change (YoY) | +1.54% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 0.85% |
| Owned by Institutions (%) | 108.08% |
| Float | 60.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.26 |
| Forward PS | 13.31 |
| PB Ratio | 40.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 2.55.
| Current Ratio | 3.76 |
| Quick Ratio | 3.56 |
| Debt / Equity | 2.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.93 |
Financial Efficiency
Return on equity (ROE) is -191.60% and return on invested capital (ROIC) is -105.00%.
| Return on Equity (ROE) | -191.60% |
| Return on Assets (ROA) | -45.30% |
| Return on Capital (ROIC) | -105.00% |
| Revenue Per Employee | $380,733 |
| Profits Per Employee | -$774,021 |
| Employee Count | 655 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.50 |
Taxes
In the past 12 months, BPMC has paid $968,000 in taxes.
| Income Tax | 968,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +78.35% in the last 52 weeks. The beta is 0.65, so BPMC's price volatility has been lower than the market average.
| Beta (1Y) | 0.65 |
| 52-Week Price Change | +78.35% |
| 50-Day Moving Average | 88.31 |
| 200-Day Moving Average | 69.16 |
| Relative Strength Index (RSI) | 42.85 |
| Average Volume (30 Days) | 770,696 |
Short Selling Information
The latest short interest is 4.37 million, so 7.14% of the outstanding shares have been sold short.
| Short Interest | 4.37M |
| Short Previous Month | 5.15M |
| Short % of Shares Out | 7.14% |
| Short % of Float | 7.22% |
| Short Ratio (days to cover) | 5.37 |
Income Statement
In the last 12 months, BPMC had revenue of $249.38 million and -$506.98 million in losses. Loss per share was -$8.37.
| Revenue | 249.38M |
| Gross Profit | 236.58M |
| Operating Income | -486.28M |
| Pretax Income | -506.02M |
| Net Income | -506.98M |
| EBITDA | -466.45M |
| EBIT | -487.22M |
| Loss Per Share | -$8.37 |
Balance Sheet
The company has $720.88 million in cash and $332.50 million in debt, giving a net cash position of $388.38 million or $6.34 per share.
| Cash & Cash Equivalents | 720.88M |
| Total Debt | 332.50M |
| Net Cash | 388.38M |
| Net Cash Per Share | $6.34 |
| Equity / Book Value | 130.61M |
| Book Value Per Share | 2.13 |
| Working Capital | 593.47M |
Cash Flow
In the last 12 months, operating cash flow was -$436.85 million and capital expenditures -$16.06 million, giving a free cash flow of -$452.91 million.
| Operating Cash Flow | -436.85M |
| Capital Expenditures | -16.06M |
| Free Cash Flow | -452.91M |
| FCF Per Share | -$7.48 |
Margins
Gross margin is 94.87%, with operating and profit margins of -194.99% and -203.30%.
| Gross Margin | 94.87% |
| Operating Margin | -194.99% |
| Pretax Margin | -202.91% |
| Profit Margin | -203.30% |
| EBITDA Margin | -187.04% |
| EBIT Margin | -195.37% |
| FCF Margin | -181.61% |
Dividends & Yields
BPMC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.54% |
| Shareholder Yield | -1.54% |
| Earnings Yield | -9.56% |
| FCF Yield | -8.54% |
Analyst Forecast
The average price target for BPMC is $83.86, which is -2.59% lower than the current price. The consensus rating is "Buy".
| Price Target | $83.86 |
| Price Target Difference | -2.59% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 33.06% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BPMC has an Altman Z-Score of -0.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.28 |
| Piotroski F-Score | 3 |